Condition: Glaucoma · Sponsor: University of Maryland, Baltimore
The purpose of this study is to establish autoregulation of retinal blood flow in arterioles and capillaries as a biomarker for early primary open angle glaucoma.
This description comes directly from the study's public registry record.
Osamah Saeedi, MD, MS · (410) 328-5929 · osaeedi@som.umaryland.edu
Always discuss trial participation with your own doctor first.
| University of Maryland Faculty Physicians, Inc | Baltimore, Maryland, United States | Recruiting |
| University of Maryland Medical Center | Baltimore, Maryland, United States | Recruiting |
| University of Maryland, Baltimore | Baltimore, Maryland, United States | Recruiting |
| Food and Drug Administration (FDA) | Silver Spring, Maryland, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05344274